Postsurgical screening for psychosocial disorders in neurooncological patients

Acta Neurochirurgica

Volumn 155, Issue 12, 2013, Pages 2255-2261

  Renovanz, M ^a   Gutenberg, A ^a   Haug, M ^b   Strittmatter, E ^c   Mazur, J ^b   Nadji Ohl, M ^d   Giese, A ^a   Hopf, N ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KATHARINENHOSPITAL   (Germany)

^c Fachklinik Hornheide   (Germany)

^d Institute of Medical Biostatistics Epidemiology and Informatics   (Germany)

Author keywords

Brain tumor; Postoperative distress; Psychosocial disorders; Screening instruments

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN TUMOR; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; DISTRESS THERMOMETER; FEMALE; FOLLOW UP; GENDER; GLIOMA; HEMANGIOBLASTOMA; HISTOLOGY; HISTOPATHOLOGY; HORNHEIDE SCREENING INSTRUMENT; HUMAN; INCIDENCE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MENTAL HEALTH CARE PERSONNEL; MIDDLE AGED; NEURILEMOMA; PATIENT REFERRAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; PSYCHOSOCIAL DISORDER; SCORING SYSTEM; THERMOMETER; TUMOR LOCALIZATION; WELLBEING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; DEPRESSION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84892156669     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-013-1884-9     Document Type: Article

References (35)

1. Angenendt G, Schütze-Kreilkamp U, Tschuschke von Haug V (2010) Praxis der Psychoonkologie: Psychoedukation, Beratung und Therapie. Stuttgart,pp 13-18
2. Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, Guill AB, Herdon JE 2nd, Raynor RH (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10(2):171-181
3. Acquaye AA, Vera-Bolanos E, Armstrong TS, Gilbert MR, Lin L (2013) Mood disturbance in glioma patients. J Neurooncol 113(3):505-512
4. Bullinger M, Siegrist J (2000). Entwicklung und klinischer Einsatz von Screening-Instrumenten zur Identifikation betreuungsbedürftiger Tumorpatienten. Lebensqualitätsforschung aus medizinpsychologischer und - soziologischer Perspektive. Jahrbuch der Medizinischen Psychologie, pp. 59-75
5. Fischbeck S, Kohlhof H, Hardt J, Hertel F, Wiewrodt D (2011) Burden and need for psychosocial intervention of glioblastoma patients. Psychother Psychosom Med Psychol 61(12):518-524
6. Flanigan JC, Jilaveanu LB, Chiang VL, Kluger HM(2013) Advances in therapy for melanoma brain metastases. Clin Dermatol 31(3):264-281
7. Goebel S, Stark AM, Kaup L, Von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psychooncology 20(6):623-630
8. Goebel S, Mehdorn HM (2011) Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol 104(1):357-364
9. Goebel S, Kaup L, Wiesner CD, Mehdorn HM (2013) Affective state and cognitive functioning in patients with intracranial tumors: validity of the neuropsychological baseline assessment. Psychooncology 22(6):1319-1327
10. Herschbach P, Heußner P, Sellschopp A (2006). Screening-Instrumente zur Ermittlung der Betreuungsbedürftigkeit von Tumorpatienten. Psychoonkologie. Perspektiven heute, pp. 122-142
11. Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS (2008) Screening for distress in patients with brain cancer using the NCCN's rapid screening measure. Psychooncology 17(6):621-625
12. Keir ST, Farland MM, Lipp ES, Friedman HS (2008) Distress persists in long-term brain tumor survivors with glioblastoma multiforme. J Cancer Surviv 2(4):269-274
13. Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM,Morrow GR,Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24:2932-2947
14. Kvale EA, Murthy R, Taylor R, Lee JY, Nabors LB (2009) Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer 17(7):793-799
15. Langley RR, Fidler IJ (2013) The biology of brain metastasis. Clin Chem 59(1):180-189
16. LindenW, Vodermaier A,Mackenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2-3):343-351
17. Litofsky NS, Farace E, Anderson F, Meyers CA, HuangW, Laws ER (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurg 54(2):358-366
18. Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2009) Somatization symptoms are related to right-hemispheric primary brain tumor: a population-based prospective study of tumor patients in northern Finland. Psychosomatics 50(4):331-335
19. Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 21(3):194-199
20. Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2011) Depression in relation to anxiety, obsessionality and phobia among neurosurgical patients with a primary brain tumor: a 1-year follow-up study. Clin Neurol Neurosurg 113(8):649-653
21. Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256(8):516-521
22. Mehnert A, Lehmann C, Schulte T, Koch U (2007) Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation. Onkologie 30(11):551-556
23. Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22: 111-122
24. Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1):46-51
25. R Core Team (2013) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL: http://www.R-project.org
26. Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61-76
27. Rumpold G, Augustin M, Zschocke I, Strittmatter G, Söllner W (2001) The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma. Psychother Psychosom Med Psychol 51(1):25-33
28. Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS (2008) Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 113(7): 1641-1648
29. Strittmatter G, Tilkorn M, Mawick R (2002) How to identify patients in need of psychological intervention. Recent Results Cancer Res 160:353-361
30. Stupp R,Mason WP, van den Bent MJ,Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA,Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996
31. Taillibert S, Laigle-Donadey F, Sanson M (2004) Palliative care in patients with primary brain tumors. Curr Opin Oncol 16(6):587-592
32. Tilkorn M, Mawick R, Sommerfeld S, Strittmatter G (1990) Quality of life of patients with malignant facial and skin tumors-development of a questionnaire and initial findings of a study. Die Rehabil (Stuttg) 29(2):134-139
33. Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81:1361-1367
34. Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167(4): 913-920
35. Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35):5874-5880